Trials / Completed
CompletedNCT02098317
DHA and Vitamin D in Children With Biopsy-proven NAFLD
Efficacy and Tolerability of Vitamin D and Docosahexaenoic Acid (DHA) in Children With Biopsy Proven NAFLD
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 66 (actual)
- Sponsor
- Bambino Gesù Hospital and Research Institute · Academic / Other
- Sex
- All
- Age
- 4 Years – 16 Years
- Healthy volunteers
- Not accepted
Summary
Non-alcoholic fatty liver disease (NAFLD) has reached epidemic proportions and is rapidly becoming the one of most common causes of chronic liver disease in children. The pathogenesis of NAFLD is generally considered the result of a series of liver injuries, commonly referred as "multi-hit" hypothesis. Several studies suggest that inflammatory pathways and oxidative stress could be responsible of disease progression. The purpose of this interventional study is to evaluate the efficacy and tolerability of docosahexaenoic acid (DHA) and Vitamin D in children and adolescents with biopsy-proven nonalcoholic fatty liver disease (NAFLD).
Detailed description
Sixty-six children or adolescents (4-16 years) with liver biopsy proven NAFLD will be enrolled. They will be randomized to treatment with DHA and Vitamin D (n=33) or an identical placebo (n=33) given orally for a period of 6 months. All patients will be included in a lifestyle intervention program consisting of a diet tailored on the individual requirements and physical exercise. Patients will undergo a medical evaluation at 3-6 and 12 months during the 12-months study period. Liver biopsy will be performed at baseline and at 12 months. Anthropometric measurements and laboratory tests, including liver enzymes, gluco-insulinemic profile and lipids will be performed at baseline and repeated at 6-12 months
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | DHA plus Vitamin D | DHA 500 mg plus Vitamin D 800 IU |
| DRUG | Placebo | Placebo pearls mimicking pearls with DHA and Vitamin D |
Timeline
- Start date
- 2014-01-01
- Primary completion
- 2015-05-01
- Completion
- 2015-09-01
- First posted
- 2014-03-28
- Last updated
- 2016-01-14
Locations
1 site across 1 country: Italy
Source: ClinicalTrials.gov record NCT02098317. Inclusion in this directory is not an endorsement.